Clinicopathologic, immunohistochemical, molecular cytogenetic profile with treatment and outcomes of 34 cases of Ewing sarcoma with epithelial differentiation, including 6 cases with "Adamantinoma-like" features, diagnosed at a single institution, India.


Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 20 06 2020
revised: 06 07 2020
accepted: 05 09 2020
pubmed: 16 9 2020
medline: 2 10 2021
entrez: 15 9 2020
Statut: ppublish

Résumé

To analyze clinicopathological features, including treatment profile of 34 cases of Ewing sarcomas with epithelial differentiation, including 6 cases with adamantinoma-like features. EWSR1 gene rearrangement was tested by fluorescence in-situ hybridization. Thirty-four tumors occurred in 19 males and 15 females (M:F = 1.26:1), with age ranging from 7 to 61 years (average = 24.2); in extremities (17), pelvis (5), paraspinal region (6), head and neck region (3), abdomen (2) and lung (1). Prior to molecular testing, 20/34(58.8%) cases were unequivocally diagnosed as Ewing sarcomas. Histopathologically, the most commonly observed pattern was nesting-type, comprising malignant round cells, including adamantinoma-like features, seen in 6 tumors. Immunohistochemically, tumor cells were diffusely positive (cytoplasmic membranous staining) for CD99/MIC2 (34/34), Fli1 (30/30); focally for synaptophysin (4/16) (25%); variably positive for AE1/AE3(31/32)(96.8%), including diffuse immunoexpression in 4 cases; EMA(6/8) and p40(3/8). All 34 (100%) tumors, tested for EWSR1 rearrangement, displayed positive results. According to the treatment details (available in 24/34 cases, 70.5%), most patients (13/24)(54.1%) were treated with surgical resection and a specific chemotherapy(CT) regimen (neoadjuvant or adjuvant settings), including 7 patients, who received adjuvant radiotherapy. During follow-up (16 cases, 47%), 5 patients developed recurrences and 8 developed metastasis, including a single, who developed recurrence. Finally, 10 patients were alive-with-disease (2-22 months); 6 free-of-disease (5-36 months). This constitutes one of the largest documentation of these rare tumors from our subcontinent, which are diagnostically challenging; require molecular confirmation and associated with treatment implications.

Identifiants

pubmed: 32932018
pii: S1092-9134(20)30171-4
doi: 10.1016/j.anndiagpath.2020.151625
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
EWSR1 protein, human 0
RNA-Binding Protein EWS 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151625

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Bharat Rekhi (B)

Department of Surgical Pathology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India; Division of Molecular Pathology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India. Electronic address: rekhi.bharat@gmail.com.

Omshree Shetty (O)

Division of Molecular Pathology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India.

Tushar Vora (T)

Department of Medical Oncology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India.

Ashish Gulia (A)

Department of Surgical Oncology (Bone and Soft Tissues), Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India.

Jyoti Bajpai (J)

Department of Medical Oncology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India.

Siddhartha Laskar (S)

Department of Radiation Oncology, Tata Memorial Hospital, Parel Homi Bhabha National Institute(HBNI) University, Mumbai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH